PE-backed Geritrex acquires portfolio of OTC topical products from PL Developments

Geritrex, a portfolio company of BelHealth Investment Partners LLC, has acquired a portfolio of OTC topical products from PL Developments. No financial terms were disclosed.

ByIris Dorbian

10 October 2018•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals North America US Healthcare Briefs

PE-backed Geritrex acquires portfolio of OTC topical products from PL Developments

Related articles